Published in Respirology on July 01, 2006
Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use. Evid Based Complement Alternat Med (2008) 1.91
Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol (2009) 1.71
Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study. J Altern Complement Med (2009) 1.30
Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol (2009) 1.08
Use of herbal remedies and adherence to inhaled corticosteroids among inner-city asthmatic patients. Ann Allergy Asthma Immunol (2010) 1.02
Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine. Mt Sinai J Med (2011) 0.98
Factors and common conditions associated with adolescent dietary supplement use: an analysis of the National Health and Nutrition Examination Survey (NHANES). BMC Complement Altern Med (2008) 0.90
Use of complementary and alternative medicine among asthmatic patients in primary care clinics in Malaysia. Ann Thorac Med (2011) 0.89
Complementary and alternative medicine use and adherence to asthma medications among Latino and non-Latino white families. Acad Pediatr (2014) 0.81
Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings. J Asthma Allergy (2009) 0.81
Bromelain Inhibits Allergic Sensitization and Murine Asthma via Modulation of Dendritic Cells. Evid Based Complement Alternat Med (2013) 0.80
Some medicinal plants with antiasthmatic potential: a current status. Asian Pac J Trop Biomed (2011) 0.78
AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med (2007) 0.78
Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases. Mediators Inflamm (2016) 0.77
The view of patients with Choronic Obstructive Pulmonary Disease (COPD) on Complementary and Alternative Medicine (CAM) in Eastern Turkey. Afr J Tradit Complement Altern Med (2013) 0.76
Anti-Inflammatory Effects of Ginsenoside Rg3 via NF-κB Pathway in A549 Cells and Human Asthmatic Lung Tissue. J Immunol Res (2016) 0.75
Patient-centered care and its effect on outcomes in the treatment of asthma. Patient Relat Outcome Meas (2011) 0.75
Complementary and alternative medicine: A survey of its use in children with chronic respiratory illness. Can J Respir Ther (2014) 0.75
Reduction of Airway Hyperresponsiveness by KWLL in Dermatophagoides-pteronyssinus-Challenged Mice. Evid Based Complement Alternat Med (2013) 0.75
Management of respiratory disorders in a Chinese medicine teaching clinic in Australia: review of clinical records. Chin Med (2015) 0.75
Characteristics of Complementary and Alternative Medicine (CAM) use among older adults with asthma. J Asthma (2016) 0.75
Patients' experiences of breathing retraining for asthma: a qualitative process analysis of participants in the intervention arms of the BREATHE trial. NPJ Prim Care Respir Med (2017) 0.75
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17
Tiotropium Respimat increases the risk of mortality. Thorax (2013) 3.34
Public health management of pandemic (H1N1) 2009 infection in Australia: a failure! Respirology (2010) 2.21
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest (2009) 2.20
Clinical control of asthma associates with measures of airway inflammation. Thorax (2012) 2.15
Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care (2005) 1.94
User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia. Respir Care (2011) 1.67
Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust (2013) 1.49
The insomnia patient perspective, a narrative review. Behav Sleep Med (2013) 1.48
Analysis of adherence to peak flow monitoring when recording of data is electronic. BMJ (2002) 1.47
Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol (2011) 1.46
Primary health care teams and the patient perspective: a social network analysis. Res Social Adm Pharm (2013) 1.45
Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol (2010) 1.41
Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol (2007) 1.41
Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns (2008) 1.37
Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma (2010) 1.35
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33
Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services. Int J Pharm Pract (2010) 1.28
IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003) (2005) 1.13
Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ (2007) 1.12
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol (2005) 1.08
RAGE and TLRs: relatives, friends or neighbours? Mol Immunol (2013) 1.05
Long-term maintenance of pharmacists' inhaler technique demonstration skills. Am J Pharm Educ (2009) 1.04
RAGE: a new frontier in chronic airways disease. Br J Pharmacol (2012) 1.04
The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med (2015) 1.00
Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med (2007) 1.00
Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma (2011) 0.99
Eosinophilic inflammation in subjects with mild-to-moderate asthma with and without obesity: disparity between sputum and biopsies. Am J Respir Crit Care Med (2014) 0.98
The reliability and patient acceptability of the SmartTrack device: a new electronic monitor and reminder device for metered dose inhalers. J Asthma (2012) 0.97
IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol (2004) 0.97
Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma (2012) 0.97
The validity and reliability of two asthma knowledge questionnaires. J Asthma (2005) 0.96
The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology (2008) 0.95
Interactive small-group asthma education in the community pharmacy setting: a pilot study. J Asthma (2007) 0.93
Multidisciplinary collaboration in primary care: through the eyes of patients. Aust J Prim Health (2013) 0.93
Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med (2002) 0.92
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res (2011) 0.91
A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol. Implement Sci (2012) 0.91
Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol (2012) 0.91
'Proliferative' and 'synthetic' airway smooth muscle cells are overlapping populations. Immunol Cell Biol (2004) 0.89
Asthma: time to confront some inconvenient truths. Respirology (2010) 0.89
Anxiety, panic and adult asthma: a cognitive-behavioral perspective. Respir Med (2006) 0.88
Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial. Prim Care Respir J (2008) 0.87
Improving paediatric asthma outcomes in primary health care: a randomised controlled trial. Med J Aust (2011) 0.87
Exasperations" of asthma: a qualitative study of patient language about worsening asthma. Med J Aust (2006) 0.87
Comparison of small-group training with self-directed internet-based training in inhaler techniques. Am J Pharm Educ (2009) 0.86
Obesity and asthma control in an urban population. J Allergy Clin Immunol (2010) 0.86
Asthma management and outcomes in Australia: a nation-wide telephone interview survey. Respirology (2007) 0.85
Short-term variability of airway caliber-a marker of asthma? J Appl Physiol (1985) (2007) 0.85
Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology (2007) 0.85
Feasibility study of a communication and education asthma intervention for general practitioners in Australia. Aust J Prim Health (2010) 0.85
Features of glossopharyngeal breathing in breath-hold divers. J Appl Physiol (1985) (2006) 0.84
Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist. Respir Med (2010) 0.83
Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1. Am J Respir Cell Mol Biol (2014) 0.83
Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma. J Appl Physiol (1985) (2004) 0.82
Insomnia patients' help-seeking experiences. Behav Sleep Med (2013) 0.82
The needs of older people with asthma. Aust Fam Physician (2007) 0.82
Authors’ response to Persson C: primary lysis/necrosis of eosinophils and clinical control of asthma. Thorax (2013) 0.82
Rhinovirus-induced exacerbations of asthma: How is the {beta}2-adrenoceptor implicated? Am J Respir Cell Mol Biol (2009) 0.81
Asthma in Indigenous Australians: so much yet to do for Indigenous lung health. Med J Aust (2009) 0.81
Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res (2012) 0.81
Innovative asthma health promotion by rural community pharmacists: a feasibility study. Health Promot J Austr (2005) 0.80
Performance of a brief asthma control screening tool in community pharmacy: a cross-sectional and prospective longitudinal analysis. Prim Care Respir J (2014) 0.80
A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. Int J Pharm Pract (2014) 0.80
Tiotropium and the risk of death in COPD. N Engl J Med (2014) 0.79
Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort study. Prim Care Respir J (2013) 0.79
Unmet needs of older people with asthma: cross-sectional survey. J Asthma (2011) 0.79
Questionnaire responses that predict airway response to hypertonic saline. Respiration (2005) 0.78
Asthma in older adults: a holistic, person-centred and problem-oriented approach. Med J Aust (2009) 0.78